BACKGROUND: Considerable uncertainty remains about obstructive lung function( OLF) in adults with metabolic syndrome (MetS). The aim of the present study was to examine pulmonary function status in adults with and without MetS. METHODS: We used data from 3109 participants aged ≥20 years of the National Health and Nutrition Examination Survey 2007-2010. Subjects'MetS status was established on the basis of the 2009 harmonizing definition. Participants received spirometry. RESULTS: After age adjustment, 79.3% (SE 1.1) of participants with MetS had normal lung function, 8.7% (0.9) had restrictive lung function (RLF), 7.1% (0.8) had mild OLF, and 4.8% (0.6) had moderate OLF or worse. Among participants without MetS, these estimates were 78.7% (1.2), 3.9% (0.6), 10.9%(1.1), and 6.4% (0.8), respectively. After multiple adjustment, participants with MetS were more likely to have RLF (adjusted prevalence ratio [aPR] 2.20; 95% confidence interval [CI] 1.67, 2.90) and less likely to have any OLF (aPR 0.73; 95% CI 0.62, 0.86) than those without MetS. Furthermore, participants with MetS had lower mean levels of forced expiratory volume in one second (FEV1), FEV1 % predicted, forced vital capacity (FVC), and FVC % predicted, but a higher FEV1/FVC ratio than participants without MetS. Mean levels of FEV1, FEV1 % predicted, FVC, and FVC % predicted declined significantly, but not the FEV1/FVC ratio, as the number of components increased. CONCLUSIONS: Compared with adults without MetS, spirometry is more likely to show a restrictive pattern and less likely to show an obstructive pattern among adults with MetS. 2014 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.
BACKGROUND: Considerable uncertainty remains about obstructive lung function( OLF) in adults with metabolic syndrome (MetS). The aim of the present study was to examine pulmonary function status in adults with and without MetS. METHODS: We used data from 3109 participants aged ≥20 years of the National Health and Nutrition Examination Survey 2007-2010. Subjects'MetS status was established on the basis of the 2009 harmonizing definition. Participants received spirometry. RESULTS: After age adjustment, 79.3% (SE 1.1) of participants with MetS had normal lung function, 8.7% (0.9) had restrictive lung function (RLF), 7.1% (0.8) had mild OLF, and 4.8% (0.6) had moderate OLF or worse. Among participants without MetS, these estimates were 78.7% (1.2), 3.9% (0.6), 10.9%(1.1), and 6.4% (0.8), respectively. After multiple adjustment, participants with MetS were more likely to have RLF (adjusted prevalence ratio [aPR] 2.20; 95% confidence interval [CI] 1.67, 2.90) and less likely to have any OLF (aPR 0.73; 95% CI 0.62, 0.86) than those without MetS. Furthermore, participants with MetS had lower mean levels of forced expiratory volume in one second (FEV1), FEV1 % predicted, forced vital capacity (FVC), and FVC % predicted, but a higher FEV1/FVC ratio than participants without MetS. Mean levels of FEV1, FEV1 % predicted, FVC, and FVC % predicted declined significantly, but not the FEV1/FVC ratio, as the number of components increased. CONCLUSIONS: Compared with adults without MetS, spirometry is more likely to show a restrictive pattern and less likely to show an obstructive pattern among adults with MetS. 2014 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.
Authors: K-B H Lam; R E Jordan; C Q Jiang; G N Thomas; M R Miller; W S Zhang; T H Lam; K K Cheng; P Adab Journal: Eur Respir J Date: 2009-07-02 Impact factor: 16.671
Authors: Fawn Yeh; Anne E Dixon; Susan Marion; Carl Schaefer; Ying Zhang; Lyle G Best; Darren Calhoun; Everett R Rhoades; Elisa T Lee Journal: Diabetes Care Date: 2011-08-18 Impact factor: 19.112
Authors: Talea Cornelius; Joseph E Schwartz; Pallavi Balte; Surya P Bhatt; Patricia A Cassano; David Currow; David R Jacobs; Miriam Johnson; Ravi Kalhan; Richard Kronmal; Laura Loehr; George T O'Connor; Benjamin Smith; Wendy B White; Sachin Yende; Elizabeth C Oelsner Journal: Am J Epidemiol Date: 2020-10-01 Impact factor: 4.897
Authors: Kathrin Kahnert; Tanja Lucke; Rudolf M Huber; Jürgen Behr; Frank Biertz; Anja Vogt; Henrik Watz; Peter Alter; Sebastian Fähndrich; Robert Bals; Rolf Holle; Stefan Karrasch; Sandra Söhler; Margarethe Wacker; Joachim H Ficker; Klaus G Parhofer; Claus Vogelmeier; Rudolf A Jörres Journal: PLoS One Date: 2017-05-15 Impact factor: 3.240
Authors: Chi Young Kim; Youngmok Park; Ah Young Leem; Kyung Soo Chung; Ji Ye Jung; Moo Suk Park; Young Sam Kim Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-06-28